Found 10 matching trials
Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations PHASE2 The purpose of this study is to compare the efficiency and safety between p...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" PHASE2 The purpose of this study is to evaluate a novel neoadjuvant regimen for in...
Show More Location
Hospital Auxilio Mutuo Cancer Center
Treatments Being Tested
Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Learn More & Join Trial
Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Royal Marsden NHS Foundation Trust - Surrey
Learn More & Join Trial
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer PHASE2 The purpose of the present study is to investigate the benefit of anti-canc...
Show More Location
Department of Oncology, Aalborg University Hospital
Learn More & Join Trial
Phase II Study of Neoadjuvant Chemotherapy Regimen Choice in Breast Cancer N/A The study purpose is to observe which neoadjuvant chemotherapy regimens is ...
Show More Location
Hospital affiliated academy military medical science
Learn More & Join Trial
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer PHASE2 Open label multicentric phase II randomized trial, using high throughput ge...
Show More Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Learn More & Join Trial
Study of Neoadjuvant Chemotherapy of Breast Cancer PHASE2 The purpose of this study is to evaluate the pathological CR rate in breast...
Show More Location
Auxilio Mutuo Cancer Center
Learn More & Join Trial
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as epirubicin and vinorelbine, ...
Show More Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Learn More & Join Trial
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS PHASE2 The objective of this Phase II, open-label, multicenter, non-randomised con...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). PHASE4 The goal of the study for patients with metastatic breast cancer (MBC) is t...
Show More Location
Agaplesion Markus Krankenhaus - Klinik für Gynäkologie und Geburtshilfe
Learn More & Join Trial